Can Three Months of Teriparatide Be One of Treatment Options for Osteoporotic Vertebral Compression Fracture Patients?

OBJECTIVE: Osteoporosis is one of the most common causes of vertebral compression fractures (VCFs). Teriparatide, a recombinant human parathyroid hormone, is the first anabolic agent for the treatment of osteoporosis. The aim of this study was to determine whether 3 months of teriparatide could be e...

Descripción completa

Detalles Bibliográficos
Autores principales: Kang, Jung Hoon, Yang, Sang Mi, Im, Soo Bin, Jeong, Je Hoon
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Korean Neurotraumatology Society 2019
Materias:
Clinical Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6495587/
https://www.ncbi.nlm.nih.gov/pubmed/31098345
http://dx.doi.org/10.13004/kjnt.2019.15.e13

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6495587/
https://www.ncbi.nlm.nih.gov/pubmed/31098345
http://dx.doi.org/10.13004/kjnt.2019.15.e13

Ejemplares similares